Published in Biotech Law Weekly, June 18th, 2004
This proprietary technology is covered by a pending patent application filed by the licenser. Imperial College Innovations will receive a license fee, milestone payments, and royalties on net sales of any resulting products.
In experiments conducted by professor Malcolm G. Parker, PhD, of Imperial College London, when this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.